Targeted therapy for hereditary cancer syndromes: neurofibromatosis type 1, neurofibromatosis type 2, and Gorlin syndrome.
Year: 2014
Type: article
Source: PubMed
Institutions: University of Cincinnati, The University of Texas Health Science Center at Houston, The University of Texas MD Anderson Cancer Center, University of Utah, Huntsman Cancer Institute, Banner MD Anderson Cancer Center, University of California San Diego, Moores Cancer Center, Vall d'Hebron Institute of Oncology
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W2403948392
